Radiotherapy for age-related macular degeneration (IPG49)
Fast, easy summary view of NICE guidance on 'eye conditions '
The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on radiotherapy for age-related macular degeneration.
This guidance was considered for reassessment in January 2011. It was concluded that NICE will not be updating this guidance as investigations have suggested that radiotherapy for age-related macular degeneration has been superseded by other techniques.
Age-related macular degeneration is the commonest cause of irreversible blindness in developed countries. Radiotherapy can be used to destroy new vessels in the wet form of maacular degeneration. It is usually given as a day treatment. The beam of radiotherapy is angled to avoid damage to the optic nerve and structures in the other eye.
C82.3 External beam radiotherapy to lesion of retina NEC
Includes: Radiotherapy to lesion of retina NEC
X65.4 Delivery of a fraction of external beam radiotherapy NEC
Y91.- External beam radiotherapy
In addition the ICD-10 code H35.3 Degeneration of macula and posterior pole would be recorded.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- IPG049 Radiotherapy for age-related macular degeneration: guidance (web format)
- IPG049 Radiotherapy for age-related macular degeneration - guidance
- IPG049 Radiotherapy for age-related macular degeneration - information for people considering the procedure, and for the public
- IPG049 Radiotherapy for age-related macular degeneration - Distribution list
- Interventional procedure consultation document - radiotherapy for age-related macular degeneration
- Overview of Radiotherapy for age-related macular degeneration
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: eye conditions
This page was last updated: 06 December 2013
Information for the public
Implementation tools and resources
- None available
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.